SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / Medicalendovascular Tech. (EVTI)


Previous 10 Next 10 
To: Bruce Hampton who wrote (1)1/27/1997 2:50:00 PM
From: Bill Tomko
   of 23
 
Thanks for the post. The most recent H&Q report that I found was Mar. 1996. ANy more recent? I basiclly like everything I have seen, except I believe( but am not sure) that Baxter is working on a completing product. Is this correct? If so do you know anything re a compare and contrast? US Surgical vs. J&J is what i keep remembering. Please let me know any thouhts you may have.

Share RecommendKeepReplyMark as Last Read


To: Bill Tomko who wrote (2)1/27/1997 5:54:00 PM
From: Bruce Hampton
   of 23
 
If the URL I posted doesn't take you directly to the material, go to hambrecht.com and select the transcript of the Jan 6-9 conference from near the top of the homepage. Lots of interesting general stuff here on 1997 lookout for biotechs, besides the EVTI mention. Also, search the database for more info on the company.

I don't know about competition but H&Q claims EVTI is way out in front of the game. Looks like years of cash burn ahead before the company hits the black, but of course, price often rises or falls on each stage of clinical phase results. I'll post again should I learn more.

Share RecommendKeepReplyMark as Last Read


To: Bruce Hampton who wrote (3)1/28/1997 10:03:00 AM
From: Bill Tomko
   of 23
 
Thanks, lets keep in touch. I have a good friend who is a vascular sur. I will try to get his input and post anythinhg meaningful that I find.

Share RecommendKeepReplyMark as Last Read


To: Bill Tomko who wrote (4)1/29/1997 7:16:00 PM
From: Bruce Hampton
   of 23
 
**News** EVTI qtr report. No surprises, no disappointments.

Check out: biz.yahoo.com

Nothing spectacular here, but at least they hit most EPS targets. The big news is that European approval is still on for mid-1997.

Share RecommendKeepReplyMark as Last Read


To: Bruce Hampton who wrote (5)1/30/1997 11:25:00 AM
From: Bruce Hampton
   of 23
 
It appears the street didn't care for this news. Checking Zacks I see where mgt missed annual expectations (actual: -1.66, estimate: 1.60), and last qtr (actual: -.49, estimate: -.43). Other news sounds OK.

Share RecommendKeepReplyMark as Last Read


To: Bruce Hampton who wrote (6)3/15/1997 8:02:00 PM
From: jay silberman
   of 23
 
This thing is quietly moving up during the high tech lynching. Anyone know why?

jay

Share RecommendKeepReplyMark as Last Read


To: Bill Tomko who wrote ()5/29/1997 8:29:00 PM
From: Rick Costantino
   of 23
 
I have recently taken a small position in EVT under $9 and plan to accumulate there. I thought I would pipe up here on the thread.

There was a decent move today...

Rick C.

Share RecommendKeepReplyMark as Last Read


To: Rick Costantino who wrote (8)5/30/1997 1:04:00 AM
From: jay silberman
   of 23
 
Rick,

I sold it on Monday; finally gave up on it, especially since the company had announced a less than rosy future. Naturally, it went up 23% today. You're welcome.

jay

Share RecommendKeepReplyMark as Last Read


To: jay silberman who wrote (9)6/3/1997 7:53:00 PM
From: Boyce Burge
   of 23
 
H&Q says buy now, the Phase II reports on efficacy are very positive.
Check at www.Hamquist.com.

The Stock does not, however, respond.

Share RecommendKeepReplyMark as Last Read


To: Boyce Burge who wrote (10)6/4/1997 12:48:00 AM
From: jay silberman
   of 23
 
It went up yesterday, didn't it?

I'm not buying - I don't want to cause myself further pain, and I don't want to take down innocent investors like yourself with me.

jay

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10